DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 153 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,325,556 | -8.6% | 118,037 | +1.0% | 0.00% | -20.0% |
| Q1 2024 | $1,450,295 | -15.1% | 116,865 | -4.4% | 0.01% | -28.6% |
| Q4 2023 | $1,708,454 | -32.6% | 122,207 | -28.8% | 0.01% | -36.4% |
| Q3 2023 | $2,533,528 | -48.9% | 171,532 | -55.3% | 0.01% | -50.0% |
| Q2 2023 | $4,954,742 | +30.9% | 383,494 | -0.6% | 0.02% | +22.2% |
| Q1 2023 | $3,784,011 | -6.9% | 385,730 | +1.0% | 0.02% | -18.2% |
| Q4 2022 | $4,063,065 | +1.9% | 381,867 | -0.0% | 0.02% | -8.3% |
| Q3 2022 | $3,989,000 | -14.4% | 382,050 | +3.3% | 0.02% | -11.1% |
| Q2 2022 | $4,658,000 | +16.2% | 369,953 | 0.0% | 0.03% | +35.0% |
| Q1 2022 | $4,010,000 | -22.7% | 369,953 | +0.4% | 0.02% | -20.0% |
| Q4 2021 | $5,185,000 | -24.8% | 368,540 | +2.7% | 0.02% | -32.4% |
| Q3 2021 | $6,893,000 | +50.8% | 358,830 | -22.7% | 0.04% | +48.0% |
| Q2 2021 | $4,570,000 | +0.2% | 463,980 | -0.0% | 0.02% | -7.4% |
| Q1 2021 | $4,563,000 | +297.5% | 464,198 | +80.0% | 0.03% | +285.7% |
| Q4 2020 | $1,148,000 | +51.1% | 257,909 | +46.6% | 0.01% | +40.0% |
| Q3 2020 | $760,000 | +523.0% | 175,875 | +1173.8% | 0.01% | +400.0% |
| Q2 2020 | $122,000 | +320.7% | 13,807 | +66.0% | 0.00% | – |
| Q1 2020 | $29,000 | +70.6% | 8,318 | +176.6% | 0.00% | – |
| Q4 2019 | $17,000 | +54.5% | 3,007 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | -8.3% | 3,007 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -69.2% | 3,007 | -43.1% | 0.00% | – |
| Q1 2019 | $39,000 | -18.8% | 5,287 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -27.3% | 5,287 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $66,000 | -7.0% | 5,287 | +13.5% | 0.00% | 0.0% |
| Q2 2018 | $71,000 | -22.8% | 4,657 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $92,000 | -40.3% | 4,657 | -43.6% | 0.00% | 0.0% |
| Q4 2017 | $154,000 | +0.7% | 8,257 | +16.0% | 0.00% | 0.0% |
| Q3 2017 | $153,000 | +1175.0% | 7,120 | +474.2% | 0.00% | – |
| Q2 2017 | $12,000 | -74.5% | 1,240 | -84.3% | 0.00% | – |
| Q1 2017 | $47,000 | +123.8% | 7,920 | +45.6% | 0.00% | – |
| Q4 2016 | $21,000 | -63.2% | 5,440 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $57,000 | +375.0% | 5,440 | +535.5% | 0.00% | – |
| Q2 2016 | $12,000 | -25.0% | 856 | 0.0% | 0.00% | – |
| Q1 2016 | $16,000 | -23.8% | 856 | 0.0% | 0.00% | – |
| Q4 2015 | $21,000 | +110.0% | 856 | +120.6% | 0.00% | – |
| Q3 2015 | $10,000 | – | 388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |